ACE2-MVP

N/A

Report date: 2025/05/07 16:33:41

Base Information

Drug NameACE2-MVP
Drug Alias NameACE2-MVP
ClassificationBiologics
Mechanisms of ActionAngiotensin-converting enzyme 2 modulators
TargetsAngiotensin-converting enzyme 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAchelois BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAchelois BioPharma Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A